Clinical Trial Watch: Bladder Cancer; Overactive Bladder

Article

This list of National Institutes of Health trials is derived from the NIH's database and includes phase III and IV bladder cancer trials and phase II overactive bladder trials. This list is current as of Sept. 15, 2011.

Bladder Cancer

Selenium in Preventing Cancer Recurrence in Patients With Bladder Cancer Sponsor(s): U.Z. Gasthuisberg
Identifier: NCT00729287

Quality of Life in Patients With Bladder Cancer Sponsor(s): University of Birmingham
Identifier: NCT00553215

Mitomycin C Versus Bacillus Calmette-Guerin in the Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer Patients Sponsor(s): Memorial Sloan-Kettering Cancer Center; New York Presbyterian Hospital; Weill Medical College of Cornell University
Identifier: NCT00974818

Effect of Dietary, Lifestyle, and Environmental Factors on Patients With Early-Stage Bladder Cancer Sponsor(s): University of Birmingham
Identifier: NCT00553566

Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer Sponsor(s): Southwest Oncology Group; National Cancer Institute (NCI)
Identifier: NCT00445601

Related Videos
Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
Peter N. Tsambarlis, MD, answers a question during a Zoom video interview
Illustration of Benign Prostatic Hyperplasia | Image Credit: © Judith - stock.adobe.com
Leonardo Kayat Bittencourt, MD, PhD, answers a question during a Zoom video interview
blur image background of corridor in hospital or clinic image | Image Credit @ whyframeshot - stock.adobe.com
Male and female surgeon performing surgery | Image Credit: © Georgii - stock.adobe.com
Related Content
© 2024 MJH Life Sciences

All rights reserved.